Revision History
Kleiner Perkins · 6 revisions
Sizes are character counts of the article source. The signed number is the change from the previous revision.
Recent edit summaries
Detailed summaries recorded by editors. Generic maintenance summaries are omitted here; every recorded revision remains below. Dates describe the edit, not necessarily the event it covers.
- Correction: Corrected the Figma IPO figures (the $1.4 billion profit and $13.5 billion market cap were unsupported; Fortune reports a $19.3 billion IPO valuation) and the Genentech founding account (Boyer shook hands with Kleiner partner Swanson, not Tom Perkins; Roche took full control in 2009 at a $100 billion valuation) (plus 15 minor fixes)
Version 6 · Nov 2, 2026, 03:08 PM
- Improve internal links (2026-10-13)
Version 4 · Oct 13, 2026, 10:11 AM
- Added 6 contextual internal links
Version 3 · Jul 23, 2026, 04:00 PM